Latest news

The new Global Guideline for the Diagnosis and Management of Candidiasis (Cornely et al., 2025) is a comprehensive review and update on the diagnosis, treatment, and prevention of Candida infections, developed by the European Confederation for Medical Mycology (ECMM) in collaboration with ISHAM and ASM. Candida species, particularly Candida auris and fluconazole-resistant Candida parapsilosis, pose […]

A recent study published in BMC Pulmonary Medicine has shed light on the clinical features and risk factors associated with invasive pulmonary aspergillosis (IPA) in patients suffering from interstitial lung disease (ILD). Most ILD patients are not immunocompromised and yet affected by IPA, as in other conditions compromising lung function. The main finding was a […]

A recent study published in the Journal of Fungi reveals that patients with multi-drug-resistant tuberculosis (MDR-TB) in Indonesia are at a significantly higher risk of co-infections with chronic pulmonary aspergillosis (CPA) and chronic pulmonary histoplasmosis (CPH). This is the first research into the incidence of CPA as a co-infection of MDR-TB patients in Indonesia in […]

A new study, conducted at Changhua Christian Hospital in Taiwan, has shed light on the varied outcomes of bacterial, tuberculous, and fungal pleural infections (empyema), a potentially life-threatening condition. Published in The International Journal of Tuberculosis and Lung Disease, the research emphasises the urgent need for tailored treatment approaches. Empyema occurs when infected fluid accumulates […]

A new case-based review published in Clinical Rheumatology highlights the precarious situation faced by patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) when complicated by invasive fungal infections (IFIs). The review, authored by Dr. Sahana Baliga and colleagues from the PD Hinduja National Hospital and Medical Research Centre, underscores the high mortality and diagnostic difficulties associated […]

Conditions caused by Aspergillus fumigatus are becoming more prevalent across the globe. This is of particular concern to the immunocompromised, and those in intensive care unit (ICU) who are admitted for prolonged periods and treated with immunosuppressive agents. Invasive aspergillosis caused by A. fumigatus is becoming more difficult to treat, as it becomes resistant to […]

Pneumocystis jirovecii pneumonia (PCP) is one of the most frequent infections seen in people with HIV. Before antiretroviral therapy (ART) became commonplace, mortality from PCP was exceptionally high if it led to respiratory failure, with an in-hospital mortality of 80%. With the advent of ART, in-hospital mortality rates have improved to around 10%. This new […]

Researchers in Brazil, led by Alessandro Pasqualotto, have shown that a 10mg/Kg single dose of liposomal amphotericin B, followed by itraconazole is at least as effective as daily liposomal amphotericin B. Clinical centres in Brazil screend 882 adult patients with HIV infection for disseminated histoplasmosis. From this sample population they randomised 118 people to be […]

Cidara Therapeutics and Melinta Therapeutics have announced that the U.S. FDA have approved Rezzayo™ (rezafungin for injection). This new medication is for the treatment and prevention of candidemia and invasive candidiasis in adults who have limited or no alternative treatment options. Rezzayo is a once-weekly injection that in clinical trials, proved to be non-inferior to […]

LIFE Worldwide, in collaboration with the Fungal Infection Trust and the University of Manchester, is pleased to announce the re-launch of its popular fungal microscopy course – www.microfungi.net  This new site has updated content, improved navigation, and more visual resources added to modules 1 and 2, with further work planned to overhaul modules 3 and […]